Free Trial
OTCMKTS:QTXB

QuantRx Biomedical (QTXB) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
$8,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About QuantRx Biomedical

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.

QTXB Stock News Headlines

Quantrx Biomedical Corp QTXB
Global Biomedical Tester Market Research Report 2022-2032
Kamala’s Dirty Election Move… Revealed
According to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move…
QTXB.PK - | Stock Price & Latest News | Reuters
See More Headlines
Receive QTXB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for QuantRx Biomedical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
9/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:QTXB
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Market Cap
$8,000.00
Optionable
Not Optionable
Beta
-2.00
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

QTXB Stock Analysis - Frequently Asked Questions

How do I buy shares of QuantRx Biomedical?

Shares of QTXB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of QuantRx Biomedical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that QuantRx Biomedical investors own include Consorcio ARA, S. A. B. de C. V. (CNRFF), Auxly Cannabis Group (CBWTF), Christopher & Banks (CBK), Babcock & Wilcox Enterprises (BW), Ascent Solar Technologies (ASTI), Arch Therapeutics (ARTH) and Amerigo Resources (ARREF).

This page (OTCMKTS:QTXB) was last updated on 9/7/2024 by MarketBeat.com Staff

From Our Partners